How to buy Midatech Pharma PLC ADR stock (MTP)

Midatech Pharma PLC ADR is a biotechnology & medical research business based in the US. Midatech Pharma PLC ADR shares (MTP) are listed on the NASDAQ and all prices are listed in US Dollars. Midatech Pharma PLC ADR employs 20 staff and has a trailing 12-month revenue of around $645,000.

Our top picks for where to buy Midatech Pharma PLC ADR stock

Buy Midatech Pharma PLC ADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Midatech Pharma PLC ADR stock price (NASDAQ: MTP)

Use our graph to track the performance of MTP stocks over time.

Midatech Pharma PLC ADR shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$1.50
200-day moving average more info button	$6.83
Wall St. target price	N/A
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-2.06

Is it a good time to buy Midatech Pharma PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Midatech Pharma PLC ADR financials

Revenue TTM	$645,000
Gross profit TTM	$578,000
Return on assets TTM	-52.5%
Return on equity TTM	-95.47%
Profit margin	0%
Book value	$7.61
Market Capitalization more info button	$2 million

TTM: trailing 12 months

Midatech Pharma PLC ADR share dividends

We're not expecting Midatech Pharma PLC ADR to pay a dividend over the next 12 months.

Have Midatech Pharma PLC ADR's shares ever split?

Midatech Pharma PLC ADR's shares were split on a 1:4 basis on 26 March 2023 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Midatech Pharma PLC ADR shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Midatech Pharma PLC ADR shares which in turn could have impacted Midatech Pharma PLC ADR's share price.

Midatech Pharma PLC ADR share price volatility

Over the last 12 months, Midatech Pharma PLC ADR's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Midatech Pharma PLC ADR's is 1.219. This would suggest that Midatech Pharma PLC ADR's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Midatech Pharma PLC ADR overview

Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom. .

Frequently asked questions

What percentage of Midatech Pharma PLC ADR is owned by institutions?
Currently 22.999% of Midatech Pharma PLC ADR shares are held by institutions. How many people work for Midatech Pharma PLC ADR?
Latest data suggests 20 work at Midatech Pharma PLC ADR. When does the fiscal year end for Midatech Pharma PLC ADR?
Midatech Pharma PLC ADR's fiscal year ends in December. Where is Midatech Pharma PLC ADR based?
Midatech Pharma PLC ADR's address is: 1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ What is Midatech Pharma PLC ADR's ISIN number?
Midatech Pharma PLC ADR's international securities identification number is: US59564R3021 What is Midatech Pharma PLC ADR's CUSIP number?
Midatech Pharma PLC ADR's Committee on Uniform Securities Identification Procedures number is: 59564R302